Preprocedural P2Y12 inhibition and decrease in platelet count following transcatheter aortic valve replacement.

Homam IbrahimEleonora VapheasBinita ShahAhmad AlkhalilMichael QuerijeroHasan JilaihawiPeter NeuburgerCezar StaniloaeMathew R Williams

Published in: Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions (2019)

Patients who received preprocedural P2Y12 inhibition prior to TAVR were less likely to demonstrate a decrease in platelet count after TAVR. Prospective studies to further understand the clinical implication of these findings are warranted.

Keyphrases

transcatheter aortic valve replacement
aortic stenosis
aortic valve
peripheral blood
ejection fraction
case control
left ventricular
coronary artery disease